What 4 Analyst Ratings Have To Say About Precision BioSciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Precision BioSciences (NASDAQ:DTIL) stock, all of them being bullish. The company has an average price target of $3.25, which has decreased by 65.17% from the previous average price target of $9.33.
September 19, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts are bullish on Precision BioSciences (DTIL), but the average price target has significantly decreased.
While the unanimous bullish sentiment from analysts is a positive sign, the significant decrease in the average price target could indicate a potential downside. This mixed signal makes the short-term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100